Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Elife ; 42015 10 27.
Artigo em Inglês | MEDLINE | ID: mdl-26506064

RESUMO

Calcium channel blockers (CCBs) are prescribed to patients with Marfan syndrome for prophylaxis against aortic aneurysm progression, despite limited evidence for their efficacy and safety in the disorder. Unexpectedly, Marfan mice treated with CCBs show accelerated aneurysm expansion, rupture, and premature lethality. This effect is both extracellular signal-regulated kinase (ERK1/2) dependent and angiotensin-II type 1 receptor (AT1R) dependent. We have identified protein kinase C beta (PKCß) as a critical mediator of this pathway and demonstrate that the PKCß inhibitor enzastaurin, and the clinically available anti-hypertensive agent hydralazine, both normalize aortic growth in Marfan mice, in association with reduced PKCß and ERK1/2 activation. Furthermore, patients with Marfan syndrome and other forms of inherited thoracic aortic aneurysm taking CCBs display increased risk of aortic dissection and need for aortic surgery, compared to patients on other antihypertensive agents.


Assuntos
Bloqueadores dos Canais de Cálcio/efeitos adversos , Síndrome de Marfan/tratamento farmacológico , Síndrome de Marfan/patologia , Adulto , Animais , Anti-Hipertensivos/administração & dosagem , Bloqueadores dos Canais de Cálcio/metabolismo , Criança , Pré-Escolar , Modelos Animais de Doenças , Humanos , Hidralazina/administração & dosagem , Indóis/administração & dosagem , Estudos Longitudinais , Sistema de Sinalização das MAP Quinases , Camundongos Endogâmicos C57BL , Proteína Quinase C beta/metabolismo , Receptor Tipo 1 de Angiotensina/metabolismo , Análise de Sobrevida , Resultado do Tratamento
2.
J Am Chem Soc ; 136(6): 2413-9, 2014 Feb 12.
Artigo em Inglês | MEDLINE | ID: mdl-24437730

RESUMO

Understanding the complex nature of diseased tissue in vivo requires development of more advanced nanomedicines, where synthesis of multifunctional polymers combines imaging multimodality with a biocompatible, tunable, and functional nanomaterial carrier. Here we describe the development of polymeric nanoparticles for multimodal imaging of disease states in vivo. The nanoparticle design utilizes the abundant functionality and tunable physicochemical properties of synthetically robust polymeric systems to facilitate targeted imaging of tumors in mice. For the first time, high-resolution (19)F/(1)H magnetic resonance imaging is combined with sensitive and versatile fluorescence imaging in a polymeric material for in vivo detection of tumors. We highlight how control over the chemistry during synthesis allows manipulation of nanoparticle size and function and can lead to very high targeting efficiency to B16 melanoma cells, both in vitro and in vivo. Importantly, the combination of imaging modalities within a polymeric nanoparticle provides information on the tumor mass across various size scales in vivo, from millimeters down to tens of micrometers.


Assuntos
Imagem Multimodal , Nanopartículas , Polímeros/síntese química , Animais , Linhagem Celular Tumoral , Células Cultivadas , Radioisótopos de Flúor , Camundongos , Microscopia Confocal , Nanopartículas/química , Polímeros/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA